1. Home
  2. CHGA vs DCOY Comparison

CHGA vs DCOY Comparison

Compare CHGA & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Change Agents Corporation Common Stock

CHGA

Change Agents Corporation Common Stock

N/A

Current Price

$2.35

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

Logo Decoy Therapeutics Inc. Common Stock

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$2.79

Market Cap

3.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHGA
DCOY
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
3.2M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
CHGA
DCOY
Price
$2.35
$2.79
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
6.5M
22.5K
Earning Date
N/A
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
33.18
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.53
52 Week High
$3.02
$13.51

Technical Indicators

Market Signals
Indicator
CHGA
DCOY
Relative Strength Index (RSI) 82.70 31.12
Support Level $0.16 $2.85
Resistance Level $3.02 $6.24
Average True Range (ATR) 0.12 0.25
MACD 0.28 0.05
Stochastic Oscillator 78.95 6.80

Price Performance

Historical Comparison
CHGA
DCOY

About CHGA Change Agents Corporation Common Stock

Change Agents Corp is an artificial intelligence software company focused on developing agentic AI applications designed to help small businesses, brands, and content creators increase revenue, improve digital discoverability, and automate content creation. The company's current portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its scalable Software-as-a-Service (SaaS) business model, it is focused on delivering AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: